Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:15:31.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434 and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T02:14:45.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T01:57:50.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T02:29:37.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with the standard site header and footer, indicating access to the study content is blocked.
    Difference
    19%
    Check dated 2026-09-20T01:18:41.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6. This change reflects a page-level update/patch and does not alter study details or core content.
    Difference
    0.1%
    Check dated 2026-08-29T21:58:29.000Z thumbnail image

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.